19 FEBRUARY 2022
09:00-10:30 SESSION 1: CERVICAL PATHOLOGY
  Presidents: M Kyrgiou, Ε. Paraskevaidis
  Comments: G. Androutsopoulos, N. Bizzarri, A. Daniilidis   
09:00-09:45 ASCCP Guidelines on the management of precancerous cervical pathology
  G. Michail
09:45-10:30 ESGO guidelines on the management of cervical cancer
  A.Papanikolaou
10:30-13:00 SESSION 2: OVARIAN PATHOLOGY
  Presidents: A. Papanikolaou, N. Vlahos, A. Sioutas  
  Comments: C. Akladios, T. Panoskaltsis
10:30-11:15 ESGO guidelines on ovarian cancer
  I. Zapardiel
11:15-12:00 ESGO guidelines on perioperative management of ovarian cancer
  D. Haidopoulos
12:00-12:30 Quality indicators of management in ovarian cancer
  F. Guyon
12:30-13:00 ESGO and SFOG guidelines for management on non-epithelial cancer in adolescent and young adults
  S. Petousis
13:00-13:15 ΒREAK
13:15-15:00 SESSION 3: ENDOMETRIAL PATHOLOGY
  Presidents: K. Dinas, G. Grimbizis 
  Comments: F. Guyon, S. Petousis   
13:15-14:00 Guidelines on the management of endometrial hyperplasia
  C. Margioula-Siarkou
14:00-15:00 ESGO Guidelines on the management of endometrial cancer
  Prof. N. Concin, ESGO President
15:00 -15:30 ΒREAK
15:30-17:00 SESSION 4: VULVAR PATHOLOGY
  Presidents: A. Daponte, E. Kontomanolis
  Comments: N. Thomakos, I. Kalogiannidis, D. Tsolakidis
15:30-16:00 Guidelines on the management of precancerous vulvar lesions
  A. Liberis
16:00-17:00 ESGO Guidelines on the management of vulvar cancer
  Prof. R. Verhaijen
17:00-17:30 SESSION 5: TROPHOBLASTIC DISEASE
  Presidents: N. Salakos, A. Sioutas
  Comments: S. Angelidou,  A. Samy
17:00-17:30  Guidelines on Trophoblastic Disease
  U. Joneborg
17:30-19:00 SESSION 6: BREAST PATHOLOGY
  Presidents: M Kalder, G. Dimitrakakis
  Comments: G-A Spyropoulou,  St. Zervoudis
17:30-18:15 NCCN guidelines on diagnostic approach of suspect breast lesions
  K. Dinas
18:15-19:00 NCCN guidelines on management of breast cancer
  M. Κalder
19:00-19:30 SESSION 7: CLOSING REMARKS
  K. Dinas, A. Papanikolaou. S. Petousis